Han Xiao

4PUBLICATIONS
44CO-AUTHORS
Radiation therapyPlanning and decision makingPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 19, 2026
Apalutamide + Abiraterone Acetate plus Prednisone + Leuprolide with Stereotactic, Ultra-Hypofractionated Radiation in Very High-Risk Prostate Cancer: A Single-Arm, Phase 2 Study.

Sean M McBride, Daniel E Spratt, Marisa Kollmeier

|Feb 04, 2026
Patients' Attitudes and Beliefs Toward Artificial Intelligence Use in Cancer Care: Cross-Sectional Survey Study.

Marco Santos Teles, Karolina Bryl, Susan Chimonas

|Jan 23, 2024
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19).

Rahul Aggarwal, Glenn Heller, David W Hillman

|Mar 30, 2023
Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial).

Michael J Morris, Glenn Heller, David W Hillman

Pageof 1

Frequent Collaborators

2 joint publications

Michael J Morris

2 joint publications

David W Hillman

2 joint publications

Alan H Bryce

2 joint publications

Susan Halabi